9/30/2021 7:33:35 AM
Teva Pharma Announces Launch Of Inhaler Tales Campaign
9/8/2021 8:11:18 AM
Teva Sees Migraine Treatment Landscape Continue To Advance; Data To Be Presented At Joint Congress 2021 On Sept 8-12
8/20/2021 8:11:22 AM
Teva Announces Analysis Of Long-Term Data Examining Treatment With
AUSTEDO Tablets In Adult With Tardive Dyskinesia
7/28/2021 7:36:18 AM
Independent Analysis Says Teva Generic Medicines Saved U.S. $28.8 Bln In 2020, Total Of $43.1 Bln Across Major Markets
7/28/2021 7:12:27 AM
Teva Pharmaceutical Industries Limited (TEVA) Has Lowered Its FY21 Revenue Estimate To $16.0 - $16.4 Bln From $16.4 - $16.8 Bln
7/28/2021 7:04:39 AM
Teva Q2 GAAP EPS $0.19; Non-GAAP EPS $0.59